看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM Ps Multiple | 4.1x - 4.6x | 4.4x |
| Selected Fwd Ps Multiple | 3.2x - 3.5x | 3.4x |
| Fair Value | ﷼133.97 - ﷼148.07 | ﷼141.02 |
| Upside | 9.8% - 21.4% | 15.6% |
| Benchmarks | Ticker | Full Ticker |
|---|---|---|
| Mouwasat Medical Services Company | 400,200.0% | SASE:4002 |
| Al Hammadi Holding Company | 400,700.0% | SASE:4007 |
| Dr. Sulaiman Al Habib Medical Services Group Company | 401,300.0% | SASE:4013 |
| Almoosa Health Company | 401,800.0% | SASE:4018 |
| Middle East Healthcare Company | 400,900.0% | SASE:4009 |
| Dallah Healthcare Company | 400,400.0% | SASE:4004 |
| Select Price / LTM Sales Ratio | ||||||||
| Benchmark Companies | ||||||||
| 4002 | 4007 | 4013 | 4018 | 4009 | 4004 | |||
| SASE:4002 | SASE:4007 | SASE:4013 | SASE:4018 | SASE:4009 | SASE:4004 | |||
| Historical Sales Growth | ||||||||
| 5Y CAGR | 9.2% | 3.4% | 17.4% | NM- | 14.0% | 20.7% | ||
| 3Y CAGR | 10.3% | 6.6% | 15.6% | 19.7% | 15.5% | 15.0% | ||
| Latest Twelve Months | 6.4% | -1.9% | 17.8% | 22.8% | 8.7% | 8.9% | ||
| Historical Net Income Profit Margin | ||||||||
| 5 Year Average Margin | 26.5% | 19.5% | 19.8% | 9.1% | 4.4% | 12.6% | ||
| Prior Fiscal Year | 24.3% | 25.8% | 21.5% | 10.0% | 0.6% | 12.2% | ||
| Latest Fiscal Year | 22.4% | 29.4% | 20.7% | 7.9% | 9.8% | 14.7% | ||
| Latest Twelve Months | 22.4% | 29.4% | 20.7% | 7.9% | 9.8% | 14.7% | ||
| Current Trading Multiples | ||||||||
| EV / LTM EBITDA | 15.7x | 16.2x | 39.3x | 34.3x | 13.9x | 18.8x | ||
| Price / LTM Sales | 5.1x | 5.6x | 9.0x | 6.2x | 2.2x | 3.8x | ||
| LTM P/E Ratio | 22.6x | 18.9x | 43.5x | 79.5x | 22.2x | 26.1x | ||
| Low | Mid | High | ||||||
| Benchmark LTM P/S Ratio | 2.2x | 5.6x | 9.0x | |||||
| Historical LTM P/S Ratio | 3.3x | 3.8x | 5.9x | |||||
| Selected Price / Sales Multiple | 4.1x | 4.4x | 4.6x | |||||
| (x) LTM Sales | 3,206 | 3,206 | 3,206 | |||||
| (=) Equity Value | 13,299 | 13,999 | 14,699 | |||||
| (/) Shares Outstanding | 101.2 | 101.2 | 101.2 | |||||
| Implied Value Range | 131.42 | 138.34 | 145.25 | |||||
| FX Rate: SAR/SAR | 1.0 | 1.0 | 1.0 | Market Price | ||||
| Implied Value Range (Trading Cur) | 131.42 | 138.34 | 145.25 | 122.00 | ||||
| Upside / (Downside) | 7.7% | 13.4% | 19.1% | |||||
| Equity Value | |||||||
| Benchmark Companies | |||||||
| (in millions) | 4002 | 4007 | 4013 | 4018 | 4009 | 4004 | |
| Value of Common Equity | 14,500 | 6,424 | 100,240 | 7,505 | 6,397 | 12,346 | |
| (/) Shares Outstanding | 200.0 | 160.0 | 350.0 | 44.3 | 92.0 | 101.2 | |
| Implied Stock Price | 72.50 | 40.15 | 286.40 | 169.40 | 69.50 | 122.00 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 72.50 | 40.15 | 286.40 | 169.40 | 69.50 | 122.00 | |
| Trading Currency | SAR | SAR | SAR | SAR | SAR | SAR | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |